138 related articles for article (PubMed ID: 8075970)
1. Teniposide for meningeal carcinomatosis of small cell lung cancer.
van der Graaf WT; Haaxma-Reiche H; Burghouts JT; Postmus PE
Lung Cancer; 1993 Dec; 10(3-4):247-9. PubMed ID: 8075970
[TBL] [Abstract][Full Text] [Related]
2. The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update.
Ettinger DS
Semin Oncol; 1995 Feb; 22(1 Suppl 2):23-7. PubMed ID: 7846538
[TBL] [Abstract][Full Text] [Related]
3. Study of either ifosfamide or teniposide compared to a standard chemotherapy for extensive disease small cell lung cancer: an Eastern Cooperative Oncology Group randomized study (E1588).
Ettinger DS; Finkelstein DM; Ritch PS; Lincoln ST; Blum RH;
Lung Cancer; 2002 Sep; 37(3):311-8. PubMed ID: 12234701
[TBL] [Abstract][Full Text] [Related]
4. A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses.
Tummarello D; Mari D; Graziano F; Isidori P; Cetto G; Pasini F; Santo A; Cellerino R
Cancer; 1997 Dec; 80(12):2222-9. PubMed ID: 9404698
[TBL] [Abstract][Full Text] [Related]
5. Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy.
Tummarello D; Graziano F; Mari D; Cetto G; Pasini F; Antonio S; Isidori P; Gasparini S
Anticancer Res; 1994; 14(5B):2221-7. PubMed ID: 7840527
[TBL] [Abstract][Full Text] [Related]
6. Second-line carboplatin-based chemotherapy for small cell lung cancer: the Groningen experience.
Postmus PE; Smit EF; Berendsen HH; Haaxma-Reiche H
Semin Oncol; 1992 Feb; 19(1 Suppl 2):17-23. PubMed ID: 1329219
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
Wolf M; Havemann K; Holle R; Gropp C; Drings P; Hans K; Schroeder M; Heim M; Dommes M; Mende S
J Clin Oncol; 1987 Dec; 5(12):1880-9. PubMed ID: 2824710
[TBL] [Abstract][Full Text] [Related]
8. Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
Havemann K; Wolf M; Drings P; Hans K; Schroeder M; Holle R; Flechtner H; Goerg R; Becker H
Semin Oncol; 1989 Feb; 16(1 Suppl 3):9-18. PubMed ID: 2539648
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy of small-cell lung cancer by a combination of teniposide, ifosfamide and carboplatin].
Moro D; Orfeuvre H; Nagy-Mignotte H; Mousseau M; Blanc-Jouvan F; Schaerer R; Brambilla C
Bull Cancer; 1994 Jan; 81(1):38-42. PubMed ID: 7949582
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two carboplatin-containing regimens with standard chemotherapy for small cell lung cancer in a randomised phase II study. The EORTC Lung Cancer Cooperative group.
Postmus PE; Splinter TA; Palmen FM; Carney DN; Festen J; Burghouts JT; Vendrik C; Roozendaal K; Planting AS; Quoix E
Eur J Cancer; 1992; 28(1):96-100. PubMed ID: 1314632
[TBL] [Abstract][Full Text] [Related]
11. Intensive therapy for small-cell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapy.
Prendiville J; Radford J; Thatcher N; Steward W; Ranson M; Burt P; Stout R
J Clin Oncol; 1991 Aug; 9(8):1446-52. PubMed ID: 1649266
[TBL] [Abstract][Full Text] [Related]
12. Testing the possible non-cross resistance of two equipotent combination chemotherapy regimens against small-cell lung cancer: a phase II study of the EORTC Lung Cancer Cooperative Group.
Postmus PE; Smit EF; Kirkpatrick A; Splinter TA
Eur J Cancer; 1993; 29A(2):204-7. PubMed ID: 8380697
[TBL] [Abstract][Full Text] [Related]
13. Ifosfamide, doxorubicin, vincristine, and etoposide in small cell lung cancer.
Elisson LO; Ekberg L
Semin Oncol; 1995 Feb; 22(1 Suppl 2):15-7. PubMed ID: 7846536
[TBL] [Abstract][Full Text] [Related]
14. Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin-etoposide hybrid chemotherapy in small cell lung cancer.
Ohnoshi T; Hiraki S; Ueoka H; Kiura K; Kamei H; Horiguchi T; Kodani T; Maeda T; Tabata M; Shibayama T
Cancer; 1993 Sep; 72(5):1597-601. PubMed ID: 8394202
[TBL] [Abstract][Full Text] [Related]
15. Dose intensity phase I/II trial with carboplatin, ifosfamide, etoposide and vincristine combined with filgrastim in patients with small-cell lung cancer.
Hanauske AR; Korfel A; Perker M; Heinrich B; Schwab G; Graf M; Depenbrock H; Höffken G; Kreuser ED; Thiel E; Zwingers T; Berdel WE
Oncology; 1997; 54(5):363-70. PubMed ID: 9260596
[TBL] [Abstract][Full Text] [Related]
16. Pilot study of teniposide in combination chemotherapy for small cell lung cancer.
Giaccone G; Schmidt G; Calciati A
Eur J Cancer; 1991; 27(2):141-3. PubMed ID: 1851021
[TBL] [Abstract][Full Text] [Related]
17. Teniposide alone and in combination chemotherapy in small cell lung cancer.
Giaccone G
Semin Oncol; 1992 Apr; 19(2 Suppl 6):75-80. PubMed ID: 1329229
[TBL] [Abstract][Full Text] [Related]
18. Standard versus alternating non-cross-resistant chemotherapy in extensive small cell lung cancer: an EORTC Phase III trial.
Postmus PE; Scagliotti G; Groen HJ; Gozzelino F; Burghouts JT; Curran D; Sahmoud T; Kirkpatrick A; Giaccone G; Splinter TA
Eur J Cancer; 1996 Aug; 32A(9):1498-503. PubMed ID: 8911108
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy with vincristine/ifosfamide/carboplatin/etoposide in small cell lung cancer.
Lorigan P; Lee SM; Betticher D; Woodhead M; Weir D; Hanley S; Hardy C; Thatcher N
Semin Oncol; 1995 Jun; 22(3 Suppl 7):32-41. PubMed ID: 7610397
[TBL] [Abstract][Full Text] [Related]
20. Extensive-stage small-cell bronchogenic carcinoma: intensive induction chemotherapy with high-dose cyclophosphamide plus high-dose etoposide.
Johnson DH; Wolff SN; Hainsworth JD; Porter LL; Grosh WW; Hande KR; Greco FA
J Clin Oncol; 1985 Feb; 3(2):170-5. PubMed ID: 2981981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
